SPONSOR
Federation Francophone de Cancerologie Digestive
Total Trials
2
Recruiting
2
Phases
Phase 3
NCT05103969
Recruiting
Cohort of Tumors With POLE/D1 Mutation
Tumors
NCT02885753 Phase 3
Recruiting
Systemic Oxaliplatin or Intra-arterial Chemotherapy Combined With LV5FU2 +/- Irinotecan and an Target Therapy in First Line Treatment of Metastatic Colorectal Cancer Restricted to the Liver
Colorectal Neoplasms